Atlas Venture Life Science Advisors, LLC Q3 2023 Filing
Filed November 13, 2023
Portfolio Value
$645.6B
Holdings
15
Report Date
Q3 2023
Filing Type
13F-HR
All Holdings (15 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | IRONDisc Medicine, Inc. | 2,745,335 | $129.0B | 19.98% | |
| 2 | DAWNDay One Biopharmaceuticals, Inc. | 7,608,394 | $93.4B | 14.46% | |
| 3 | DYNDyne Therapeutics, Inc. | 9,885,449 | $88.6B | 13.72% | |
| 4 | KYMRKymera Therapeutics, Inc. | 5,858,262 | $81.4B | 12.61% | |
| 5 | THRDThird Harmonic Bio, Inc. | 10,907,859 | $69.7B | 10.80% | |
| 6 | REPLReplimune Group, Inc. | 2,098,300 | $35.9B | 5.56% | |
| 7 | VIGLVigil Neuroscience, Inc. | 5,836,874 | $31.5B | 4.87% | |
| 8 | GBIOGBXGeneration Bio, Co. | 8,279,484 | $31.4B | 4.86% | |
| 9 | AVTEAerovate Therapeutics, Inc. | 2,039,249 | $27.7B | 4.29% | |
| 10 | —Ikena Oncology, Inc. | 5,018,178 | $21.7B | 3.37% | |
| 11 | AKROAkero Therapeutics, Inc. | 359,251 | $18.2B | 2.81% | |
| 12 | —AvroBio, Inc. | 4,541,381 | $7.0B | 1.08% | |
| 13 | XLOXilio Therapeutics, Inc. | 2,759,344 | $5.8B | 0.90% | |
| 14 | DNTHDianthus Therapeutics, Inc. | 236,979 | $3.2B | 0.50% | |
| 15 | SPROSpero Therapeutics, Inc. | 1,013,438 | $1.2B | 0.19% |